NEW THERAPY OFFERS HOPE FOR BONE MARROW CANCER

Published:2019-05-03


A new therapy developed by Chinese researchers to treat bone marrow cancer has completed its first phase of clinical trials with a response rate of 90 percent.


The high response rate suggests the therapy might significantly raise the five-year survival rate of patients with multiple myeloma, which currently stands at 50.7 percent.

SITE MAP

World Time

  • SENEGAL | DAKAR:07.09 05:57

  • NIGERIA | LAGOS:07.09 06:57

  • EGYPT | CAIRO:07.09 07:57

  • UAE | DUBAI:07.09 09:57

  • SRI LANKA | COLOMBO:07.09 11:27

  • SINGAPORE:07.09 13:57

  • ENGLAND | LONDON:07.09 06:57

  • RUSSIA | MOSCOW:07.09 09:57

  • CHINA | BEIJING:07.09 13:57

  • AMERICA | Los Angels:07.08 22:57

  • AMERICA | New York:07.09 01:57

  • BRAZIL | San Paulo:07.09 02:57